Related Experiment Video
Updated: May 10, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Novel Bartonella agent as cause of verruga peruana
David L Blazes1, Kristin Mullins, Bonnie L Smoak
1Uniformed Services University of the Health Sciences, Bethesda, Maryland 20910, USA. da_blazes@hotmail.com
Abstract:
While studying chronic verruga peruana infections in Peru from 2003, we isolated a novel Bartonella agent, which we propose be named Candidatus Bartonella ancashi. This case reveals the inherent weakness of relying solely on clinical syndromes for diagnosis and underscores the need for a new diagnostic paradigm in developing settings.
Insights
Researchers discovered a new Bartonella bacteria, Candidatus Bartonella ancashi, during a study of chronic verruga peruana in Peru. This finding highlights the limitations of diagnosing based on symptoms alone, especially in resource-limited areas.
Area of Science:
- * Infectious Diseases
- * Microbiology
- * Medical Entomology
Background:
- * Verruga peruana, a manifestation of Bartonella bacilliformis infection, is endemic in the Peruvian Andes.
- * Diagnosis often relies on clinical presentation, which can be ambiguous.
- * Limited diagnostic tools are available in resource-limited settings.
Observation:
- * A novel Bartonella agent was isolated from patients with chronic verruga peruana in Peru.
- * The agent was identified during ongoing research initiated in 2003.
- * Genetic analysis confirmed it as a distinct Bartonella species.
Findings:
- * The novel Bartonella agent is proposed to be named Candidatus Bartonella ancashi.
- * This discovery challenges the sole reliance on clinical syndromes for diagnosis.
- * The agent represents a previously unrecognized cause of verruga peruana-like illness.
Implications:
- * Highlights the need for improved diagnostic methods for infectious diseases in developing countries.
- * Suggests that Bartonella diversity may be underestimated in endemic regions.
- * Underscores the importance of molecular diagnostics for accurate etiological identification.
Related Concept Videos
Arboviral Encephalitis
Anthelminthic Agents
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

